[HTML][HTML] Current FDA-approved therapies for high-grade malignant gliomas

JP Fisher, DC Adamson - Biomedicines, 2021 - mdpi.com
The standard of care (SOC) for high-grade gliomas (HGG) is maximally safe surgical
resection, followed by concurrent radiation therapy (RT) and temozolomide (TMZ) for 6 …

[HTML][HTML] Glioblastoma treatment modalities besides surgery

H Zhang, R Wang, Y Yu, J Liu, T Luo, F Fan - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Glioblastoma multiforme (GBM) is commonly known as the most aggressive primary CNS
tumor in adults. The mean survival of it is 14 to 15 months, following the standard therapy …

Personalized radiotherapy design for glioblastoma: integrating mathematical tumor models, multimodal scans, and Bayesian inference

J Lipková, P Angelikopoulos, S Wu… - IEEE transactions on …, 2019 - ieeexplore.ieee.org
Glioblastoma (GBM) is a highly invasive brain tumor, whose cells infiltrate surrounding
normal brain tissue beyond the lesion outlines visible in the current medical scans. These …

The radiosurgery fractionation quandary: single fraction or hypofractionation?

JP Kirkpatrick, SG Soltys, SS Lo, K Beal… - Neuro …, 2017 - academic.oup.com
Stereotactic radiosurgery (SRS), typically administered in a single session, is widely
employed to safely, efficiently, and effectively treat small intracranial lesions. However, for …

[HTML][HTML] Predictive digital twin for optimizing patient-specific radiotherapy regimens under uncertainty in high-grade gliomas

A Chaudhuri, G Pash, DA Hormuth… - Frontiers in Artificial …, 2023 - frontiersin.org
We develop a methodology to create data-driven predictive digital twins for optimal risk-
aware clinical decision-making. We illustrate the methodology as an enabler for an …

Radiation dose‐enhancement is a potent radiotherapeutic effect of rare‐earth composite nanoscintillators in preclinical models of glioblastoma

AL Bulin, M Broekgaarden, F Chaput… - Advanced …, 2020 - Wiley Online Library
To improve the prognosis of glioblastoma, innovative radiotherapy regimens are required to
augment the effect of tolerable radiation doses while sparing surrounding tissues. In this …

High dose bystander effects in spatially fractionated radiation therapy

R Asur, KT Butterworth, JA Penagaricano, KM Prise… - Cancer letters, 2015 - Elsevier
Traditional radiotherapy of bulky tumors has certain limitations. Spatially fractionated
radiation therapy (GRID) and intensity modulated radiotherapy (IMRT) are examples of …

[HTML][HTML] Clinical application of MR-Linac in tumor radiotherapy: a systematic review

X Liu, Z Li, Y Yin - Radiation Oncology, 2023 - Springer
Recent years have seen both a fresh knowledge of cancer and impressive advancements in
its treatment. However, the clinical treatment paradigm of cancer is still difficult to implement …

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma

A Omuro, K Beal, P Gutin, S Karimi, DD Correa… - Clinical Cancer …, 2014 - AACR
Purpose: Bevacizumab is associated with decreased vascular permeability that allows for
more aggressive radiotherapy schedules. We conducted a phase II trial in newly diagnosed …

[HTML][HTML] Molecular pathways implicated in radioresistance of glioblastoma multiforme: what is the role of extracellular vesicles?

P Burko, G D'Amico, I Miltykh, F Scalia… - International Journal of …, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is a primary brain tumor that is very aggressive, resistant to
treatment, and characterized by a high degree of anaplasia and proliferation. Routine …